pipette
ENEnglish

Catalytic Uncaging of Anticancer Drugs via a Buchner Ring Expansion

Damian Alexander Graf, Nicole Rathfelder, Boris V. Lozhkin, Thomas R. Ward

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Abstract Selective drug activation in living systems remains a central challenge in targeted cancer therapy. Bioorthogonal catalysis addresses this by using abiotic transition-metal catalysts to unmask prodrugs at the tumor site, but the repertoire of suitable reactions remains limited. Here, we exploit the Buchner ring-expansion as a new uncaging strategy, in which a metal-carbene catalyzes a regioselective intramolecular ring-expansion followed by spontaneous 1,6-elimination to release a caged payload─a cascade with no biological equivalent. The iridium porphyrin complex [Ir(mPIX)Me] catalyzes this reaction at nanomolar concentrations, and the platform can accommodate structurally diverse payloads. As a proof of concept, functionalization with a bivalent human carbonic anhydrase IX (hCA IX) inhibitor enabled tumor-selective release of epirubicin (Epi) in a cancer cell model. This work thus delineates a new reaction class to the growing toolkit of transition-metal-mediated bioorthogonal chemistry.

Resultado principalEl resumen no menciona limitaciones.

Apareció: jueves, 29 de octubre. Journal of the American Chemical Society. Revista con revisión por pares.

DOI: 10.1021/jacs.6c14207